Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症如果利尿效果不佳或合并有心力衰竭或高容量时,可以液透治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 高对长期液透获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Applied during hemodialysis, the effect rate were 8.3%, 71.4%, 68.2% respectively in midodrine hydrochloride tablet group compound amino acid group, 50% glucose group.

在透中出现症状后应用，有效率分别为：盐酸米多君8.3%，复方氨基酸71.4%，50%葡萄糖68.2%。